| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 07/27/2005 | EP1556387A1 Substituted benzol e] 1,4] oxazino 3,2-g] isoindole derivatives, method for preparing same and pharmaceutical compositions containing same |
| 07/27/2005 | EP1556384A2 Pyrimido compounds having antiproliferative activity |
| 07/27/2005 | EP1556382A1 3-phenyl substituted pyridoindolone, preparation and therapeutic use thereof |
| 07/27/2005 | EP1556380A1 Pyridoindolone derivatives substituted in the 3-position by a heterocyclic group, preparation thereof and application of same in therapeutics |
| 07/27/2005 | EP1556375A2 Flavone derivatives as inhibitors of cyclin-dependent kinases |
| 07/27/2005 | EP1556374A2 Benzopyranone compounds, compositions thereof, and methods for treating or preventing cancer |
| 07/27/2005 | EP1556368A1 Aminated isoflavonoid derivatives and uses thereof |
| 07/27/2005 | EP1556357A1 Compounds, compositions, and methods |
| 07/27/2005 | EP1556339A2 Carboxyalkoxy-substituted acyl-carboxyphenyl-urea derivatives, production method and use thereof as medicine |
| 07/27/2005 | EP1556142A2 Alkyne derivatives as tracers for metabotropic glutamate receptor binding |
| 07/27/2005 | EP1556088A2 Compositions for cancer treatment |
| 07/27/2005 | EP1556082A1 Anti-cancer vaccines and high-dose cytokines as adjuvants |
| 07/27/2005 | EP1556074A2 Casein derived peptides and uses thereof in therapy |
| 07/27/2005 | EP1556073A2 Method and composition for preventing and treating solid tumors |
| 07/27/2005 | EP1556066A2 Compositions and methods of use for a fibroblast growth factor |
| 07/27/2005 | EP1556058A1 Pharmaceutical compositions comprising estetrol derivatives for use in cancer therapy |
| 07/27/2005 | EP1556033A1 Methods and compositions using selective cytokine inhibitory drugs for treatment and management of cancers and other diseases |
| 07/27/2005 | EP1556029A2 Thiomolybdate analogues and uses thereof |
| 07/27/2005 | EP1432709B1 1-glyoxlylamide indolizines for treating cancer |
| 07/27/2005 | EP1414384A4 Synthesis of epothilones and relates analogs |
| 07/27/2005 | EP1379523B1 1,2,3,4-tetrahydroisoquinolines derivatives as urotensin ii receptor antagonists |
| 07/27/2005 | EP1377573B1 Pyrazolopyridine derivatives |
| 07/27/2005 | EP1339711B1 Aminothiazoles and their use as adenosine receptor antagonists |
| 07/27/2005 | EP1318992B1 Imidazole derivatives as raf kinase inhibitors |
| 07/27/2005 | EP1289559B1 Combinations of enzyme inhibitor-containing preparations and the use thereof |
| 07/27/2005 | EP1287004B1 Synthetic process for the manufacture of an ecteinascidin compound |
| 07/27/2005 | EP1283823A4 Novel mmp-2/mmp-9 inhibitors |
| 07/27/2005 | EP1277754B1 Imidazopyridine derivatives |
| 07/27/2005 | EP1272185B1 Use of quinazoline derivatives as angiogenesis inhibitors |
| 07/27/2005 | EP1263757B1 Benzthiazoles as tnf and pde-iv inhibitors |
| 07/27/2005 | EP1257299B1 Radioactive therapeutic liposomes |
| 07/27/2005 | EP1237877B1 Carboxamide-substituted benzimidazol derivatives, methods for the production thereof and their use as medicaments |
| 07/27/2005 | EP1214063B1 Treating cancer using tetraethyl thiuram disulfide |
| 07/27/2005 | EP1206539B1 Medicament for the prevention and/or the treatment of ischemic heart and peripheral vascular diseases, tumour and wounds |
| 07/27/2005 | EP1047418B1 Inhibition of raf kinase using substituted heterocyclic ureas |
| 07/27/2005 | EP1025236B1 Human checkpoint kinase, hcds1, compositions and methods |
| 07/27/2005 | EP1009402B1 Compositions and use of benzamides as anti-inflammatory agents |
| 07/27/2005 | EP0954299B1 Thyroxine analogues having no significant hormonal activity for treating malignant tumours |
| 07/27/2005 | EP0920510B1 GnRH-LEUKOTOXIN CHIMERAS |
| 07/27/2005 | CN2712931Y Electromagnetic cleavage device for cleavage extracting polypeptide from vegetable protein |
| 07/27/2005 | CN1646703A Compositions and methods for detection and treatment of proliferative abnormalities associated with overexpression of human transketolase like-1 gene |
| 07/27/2005 | CN1646700A Methods for determining the response of cells to VEGF and uses thereof |
| 07/27/2005 | CN1646693A Enveloped microorganism |
| 07/27/2005 | CN1646692A Genetic products differentially expressed in tumors and use thereof |
| 07/27/2005 | CN1646688A Growth regulating proteins |
| 07/27/2005 | CN1646684A Recombinant parainfluenza virus expression systems and vaccines comprising heterologous antigens derived from metapneumovirus |
| 07/27/2005 | CN1646567A Anti-idiotype anti-CEA antibody molecules and its use as cancer vaccine |
| 07/27/2005 | CN1646566A Induction of anti-tumor CTL immunity through in vivo triggering of 4-1BB and/or CD40 |
| 07/27/2005 | CN1646563A Compositions and methods for the therapy and diagnosis of breast cancer |
| 07/27/2005 | CN1646562A Pluripotency determining factors and uses thereof |
| 07/27/2005 | CN1646558A Histone deacetylase inhibitors and process for producing the same |
| 07/27/2005 | CN1646539A The synthesis of naturally occuring ecteinascidins and related compounds |
| 07/27/2005 | CN1646537A Phosphorus-containing compounds & uses thereof |
| 07/27/2005 | CN1646535A Pyrrolopyrimidine derivative |
| 07/27/2005 | CN1646534A Modified fluorinated nucleoside analogues |
| 07/27/2005 | CN1646533A 1-[alkyl], 1-[heteroaryl]alkyl] and 1-[aryl]alkyl]-7-(pyrimidin-4-yl)-imadazo[1, 2-a]pyrimidin-5(1H)-one derivatives |
| 07/27/2005 | CN1646531A Thioxanthine derivatives as myeloperoxidase inhibitors |
| 07/27/2005 | CN1646526A Tropane derivatives as CCR5 modulators |
| 07/27/2005 | CN1646524A Benzopyran derivatives substituted with secondary amines including tetrazole, method for the preparation thereof and pharmaceutical compositions containing them |
| 07/27/2005 | CN1646520A 1, 3, 5-triazine derivatives as ligands for human adenosine-A3 receptors |
| 07/27/2005 | CN1646519A N-oxyde of N-phenyl-2-pyrimidine-amine derivatives |
| 07/27/2005 | CN1646509A Piperazinyl- or piperidinylamine-sulfamic acid amides as inhibitors of steroid sulfatase |
| 07/27/2005 | CN1646508A 5-substituted 1, 1-dioxo-1, 2, 5-thiazolidine-3-one derivatives as PTP ase 1B inhibitors |
| 07/27/2005 | CN1646505A Oxa- and thiadiazoles and their use as metalloproteinase inhibitors |
| 07/27/2005 | CN1646504A Substituted benzoxazoles and analogues as estrogenic agents |
| 07/27/2005 | CN1646495A Amine compounds and use thereof |
| 07/27/2005 | CN1646492A Chain oligolactic acid thioester |
| 07/27/2005 | CN1646491A Compounds used to prepare camptothecin derivatives |
| 07/27/2005 | CN1646479A Irreversible selective androgen receptor modulators and methods of use thereof |
| 07/27/2005 | CN1646473A Novel curcumin analogues and uses thereof |
| 07/27/2005 | CN1646460A 2-(2, 6-dichlorophenyl)-diarylimidazoles |
| 07/27/2005 | CN1646161A Reagents and treatment methods for autoimmune diseases |
| 07/27/2005 | CN1646160A Anti-alpha V beta 6 antibodies |
| 07/27/2005 | CN1646159A Immunoadjuvant |
| 07/27/2005 | CN1646155A Cancer therapy |
| 07/27/2005 | CN1646154A Albumin-fused anti-angiogenesis peptides |
| 07/27/2005 | CN1646152A Mannose binding lectin and uses thereof |
| 07/27/2005 | CN1646148A Drugs including anticancer agents and immunopotentiators and health foods and drinks |
| 07/27/2005 | CN1646147A Method and composition for targeting of a systemically generated immune response to a specific organ or tissue |
| 07/27/2005 | CN1646143A Combination of a beta-2 adrenoceptor agonists and an aminosugars and their use for the treatment immunomodulatory disorders |
| 07/27/2005 | CN1646141A Modified nucleosides for treatment of viral infections and abnormal cellular proliferation |
| 07/27/2005 | CN1646136A Pharmaceutical compositions comprising active vitamin D compounds |
| 07/27/2005 | CN1646131A Novel compounds |
| 07/27/2005 | CN1646129A Dosing regimen for gemcitabine HCV therapy |
| 07/27/2005 | CN1646120A Antineoplastic combinations |
| 07/27/2005 | CN1646119A Therapeutic methods and compositions involving isoflav-3-ene and isoflavan structures |
| 07/27/2005 | CN1646117A Low-pressure mercury vapor discharge lamp |
| 07/27/2005 | CN1646112A A herbal molecule as potential anti-leukemic drug |
| 07/27/2005 | CN1646103A 高药物载荷片剂 High drug load tablets |
| 07/27/2005 | CN1646101A Method for the production of crystals, crystals obtained by said method, and use thereof in pharmaceutical formulations |
| 07/27/2005 | CN1646100A Dispersed solid-containing complex carbohydrate |
| 07/27/2005 | CN1646097A Chemosensitizing with liposomes containing oligonucleotides |
| 07/27/2005 | CN1646090A New composition including a pigment assembly comprising a mica core |
| 07/27/2005 | CN1644705A Metabolic compound of HLY2 and its preparation |
| 07/27/2005 | CN1644701A Tumour cell specific eucaryon expressing carriers |
| 07/27/2005 | CN1644697A Thioredoxin peroxidase gene of China Qingdao branchiostoma and use thereof |
| 07/27/2005 | CN1644214A YG and YGG used as maintenance and improvement of immunoreaction |
| 07/27/2005 | CN1644213A Chinese medicinal preparation for treating liver cancer, hepatitis B cirrhosis and preventing liver fibrillation and preparation thereof |
| 07/27/2005 | CN1644202A Cucurbitacin liquid composition and preparation thereof |
| 07/27/2005 | CN1644201A Application of folic acid-containing pharmaceutical compositions |